Hi-Tech Pharmacal Co Inc - ESG Rating & Company Profile powered by AI
Jump to the bottom of the page for potential risks for Hi-Tech Pharmacal Co Inc based on industry, location and size. Other companies in the rating peer group for Hi-Tech Pharmacal Co Inc are shownin the table. Complete Sustainability assessment of Hi-Tech Pharmacal Co Inc can be reached by signing in.
Hi-Tech Pharmacal Co Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Hi-Tech Pharmacal Co Inc | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Hi-Tech Pharmacal Co Inc have an accelerator or VC vehicle to help deliver innovation?
Does Hi-Tech Pharmacal Co Inc disclose current and historical energy intensity?
Does Hi-Tech Pharmacal Co Inc report the average age of the workforce?
Does Hi-Tech Pharmacal Co Inc reference operational or capital allocation in relation to climate change?
Does Hi-Tech Pharmacal Co Inc disclose its ethnicity pay gap?
Does Hi-Tech Pharmacal Co Inc disclose cybersecurity risks?
Does Hi-Tech Pharmacal Co Inc use carbon offsets or credits exclusively for residual emissions (typically less than ~0.5–5% of total emissions)?
Does Hi-Tech Pharmacal Co Inc offer flexible work?
Does Hi-Tech Pharmacal Co Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Hi-Tech Pharmacal Co Inc disclose the number of employees in R&D functions?
Does Hi-Tech Pharmacal Co Inc plan to change its portfolio composition to lower the emissions intensity of its energy mix (e.g., by shifting from oil to gas, or by adding lower-carbon options like hydrogen, e-fuels, bioenergy, etc.)?
Does Hi-Tech Pharmacal Co Inc conduct supply chain audits?
Does Hi-Tech Pharmacal Co Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Hi-Tech Pharmacal Co Inc conduct 360 degree staff reviews?
Does Hi-Tech Pharmacal Co Inc disclose the individual responsible for D&I?
Does Hi-Tech Pharmacal Co Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Hi-Tech Pharmacal Co Inc disclose current and / or historical scope 2 emissions?
Does Hi-Tech Pharmacal Co Inc disclose water use targets?
Does Hi-Tech Pharmacal Co Inc have careers partnerships with academic institutions?
Did Hi-Tech Pharmacal Co Inc have a product recall in the last two years?
Does Hi-Tech Pharmacal Co Inc disclose incidents of discrimination?
Does Hi-Tech Pharmacal Co Inc allow for Work Councils/Collective Agreements to be formed?
Has Hi-Tech Pharmacal Co Inc issued a profit warning in the past 24 months?
Does Hi-Tech Pharmacal Co Inc disclose parental leave metrics?
Does Hi-Tech Pharmacal Co Inc disclose climate scenario or pathway analysis?
Does Hi-Tech Pharmacal Co Inc disclose current and / or historical scope 1 emissions?
Does Hi-Tech Pharmacal Co Inc explicitly state that carbon offsets or credits are separate from its emissions-reduction progress or that they are not counted toward its emissions-reduction targets?
Are Operating Expesnses linked to emissions reduction?
Does Hi-Tech Pharmacal Co Inc disclose the pay ratio of women to men?
Does Hi-Tech Pharmacal Co Inc support suppliers with sustainability related research and development?
Does Hi-Tech Pharmacal Co Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Hi-Tech Pharmacal Co Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Hi-Tech Pharmacal Co Inc involved in embryonic stem cell research?
Does Hi-Tech Pharmacal Co Inc disclose GHG and Air Emissions intensity?
Does Hi-Tech Pharmacal Co Inc disclose its waste policy?
Does Hi-Tech Pharmacal Co Inc report according to TCFD requirements?
Does Hi-Tech Pharmacal Co Inc plan to mitigate emissions from future new production assets through measures such as electrifying equipment, carbon capture and storage, repurposing waste gas, methane leak detection and repair, eliminating flaring, etc.?
Does Hi-Tech Pharmacal Co Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Hi-Tech Pharmacal Co Inc disclose energy use targets?
Does Hi-Tech Pharmacal Co Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Hi-Tech Pharmacal Co Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Hi-Tech Pharmacal Co Inc
These potential risks are based on the size, segment and geographies of the company.